文献速递鼻科头颈外科

鼻腔鼻窦副神经节瘤的特征与管理:一项系统综述

Characteristics and management of sinonasal paragangliomas: a systematic review.
PubMed 文献 · Int Forum Allergy Rhinol · 2018-12-20

该系统综述纳入45项研究共54例鼻腔鼻窦副神经节瘤患者,最常见部位为鼻腔(66.7%),常见症状为复发性鼻出血(68.5%)和鼻塞(53.7%);恶性肿瘤占28.6%,初次治疗均为手术(开放63.0%、内镜33.3%),复发率21.7%,总生存率87.0%,转移率8.7%。

要点

  • 鼻腔鼻窦副神经节瘤常表现为复发性鼻出血和鼻塞,恶性肿瘤占28.6%。
  • 初次治疗均为手术,开放入路63.0%、内镜入路33.3%,放疗作为辅助治疗用于10例(18.5%)。
  • 复发率21.7%,复发发生在初次切除后12至156个月,总生存率87.0%,转移率8.7%。

核心结论

  • 鼻腔鼻窦副神经节瘤是血管性肿瘤,临床表现为复发性鼻出血和鼻塞。
  • 治疗目标为完整切除并切缘阴性,因有局部复发倾向需长期随访。
  • 放疗已作为辅助治疗使用,结果不一;进一步的随机对照研究可能对阐明这些发现非常有价值。

研究设计与样本

  • 遵循PRISMA指南的系统文献综述,检索鼻腔鼻窦副神经节瘤相关研究。
  • 纳入符合标准的研究并评估证据等级,共纳入45项相关研究、54例患者。
  • 评估内容包括患者人口学特征、肿瘤特征、主要干预措施及其他临床特征。

主要发现

  • 最常见肿瘤部位为鼻腔(66.7%)、筛窦(22.2%)、上颌窦(7.4%)和蝶窦(3.7%)。
  • 常见症状包括复发性鼻出血(68.5%)、鼻塞(53.7%)和头痛(13.0%)。
  • 恶性肿瘤占28.6%,仅4例(7.4%)为功能性肿瘤。
  • 初次治疗均为手术,开放入路占63.0%、内镜入路占33.3%;放疗作为辅助治疗用于10例(18.5%)。
  • 复发率为21.7%,复发发生在初次切除后12至156个月;总生存率87.0%,转移率8.7%。

关键数值与推荐

  • 恶性肿瘤占28.6%,功能性肿瘤占7.4%(4例)。
  • 开放手术占63.0%,内镜手术占33.3%,辅助放疗占18.5%(10例)。
  • 复发率21.7%,复发时间12至156个月,总生存率87.0%,转移率8.7%。

临床怎么用

  • 原文指出治疗目标为完整切除并切缘阴性,因有局部复发倾向需长期随访。
  • 原文指出放疗已作为辅助治疗使用,结果不一。
  • 原文未据此给出其他推荐。

局限性

  • 原文结论指出进一步的随机对照研究可能对阐明这些发现非常有价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Paragangliomas of the nasal cavity and paranasal sinuses, although exceedingly rare, can exhibit frequent and aggressive recurrences. Our objective was to evaluate tumor characteristics, clinical course, management, and associated complications of sinonasal paragangliomas METHODS: A systematic review of the literature was performed utilizing the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines, searching for sinonasal paraganglioma. Studies meeting inclusion criteria were assessed for level of evidence. Patient demographics, tumor characteristics, primary intervention, and other clinical characteristics were evaluated. RESULTS: Forty-five relevant studies encompassing 54 patients with sinonasal paraganglioma were identified. The most common tumor locations were the nasal cavity (66.7%), ethmoid sinuses (22.2%), maxillary sinuses (7.4%), and sphenoid sinuses (3.7%). Common presenting symptoms included recurrent epistaxis (68.5%), nasal obstruction (53.7%), and headache (13.0%). Tumors were malignant in 28.6% of patients. Only 4 cases (7.4%) involved functional tumors. Initial management was always surgical, via either an open (63.0%) or endoscopic (33.3%) approach. Radiotherapy was used as adjunctive treatment in 10 cases (18.5%). Recurrence rate was 21.7% and occurred between 12 to 156 months after initial resection. The overall survival was 87.0% with a metastatic rate of 8.7%. CONCLUSION: Sinonasal paragangliomas are vascular neoplasms manifesting clinically with recurrent epistaxis and nasal obstruction. Management goals are total resection with clear margins and long-term follow-up due to tendency for local recurrence. Radiotherapy has been utilized as adjuvant therapy with variable results. Further randomized controlled studies may be invaluable in elucidating these findings.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Nguyen BK, Patel NM, Arianpour K, et al. Characteristics and management of sinonasal paragangliomas: a systematic review. Int Forum Allergy Rhinol. 2018. PMID: 30570216. doi:10.1002/alr.22261

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。